Novartis' Generics Acquisition Strategy Aims To Add Products, Not Size
This article was originally published in The Pink Sheet Daily
Executive Summary
Novartis' acquisition strategy for its generics business aims to strengthen Sandoz' negotiating capability with chain pharmacies by adding products to its portfolio rather than simply increasing the business' scale.